Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rivaroxaban Dabigatran'

Rivaroxaban Dabigatran published presentations and documents on DocSlides.

Rivaroxaban compared with enoxaparin for the prevention of

Rivaroxaban compared with enoxaparin for the prevention of

  • luanne-stotts
  • 21 Slides

Alexander T Cohen . On behalf of the MAGELLAN Ste...

Update on the New Oral Anticoagulants

Update on the New Oral Anticoagulants

  • sherrill-nordquist
  • 39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • debby-jeon
  • 46 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Novel Oral Anticoagulants

Novel Oral Anticoagulants

  • natalia-silvester
  • 88 Slides

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

Alexander G

Alexander G

  • min-jolicoeur
  • 35 Slides

G. . Turpie. Professor Emeritus of Medicine. McM...

Management of

Management of

  • marina-yarberry
  • 74 Slides

Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...

Concomitant Antiplatelet and OAC

Concomitant Antiplatelet and OAC

  • kittie-lecroy
  • 8 Slides

Tx. : . Real-World Practice. In the US, ~800,000 ...

Recent ACS: STEMI, NSTEMI, UA

Recent ACS: STEMI, NSTEMI, UA

  • danika-pritchard
  • 20 Slides

Stabilized 1-7 Days Post-Index Event. Exclusions:...

Direct Oral Anticoagulants

Direct Oral Anticoagulants

  • debby-jeon
  • 53 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

Oral anticoagulants in the 21

Oral anticoagulants in the 21

  • natalia-silvester
  • 50 Slides

st. century: A practical guide to using newer A...

Dodson Thompson, DO

Dodson Thompson, DO

  • lois-ondreau
  • 40 Slides

Northlakes. Community Clinic. Minong, WI. Novel ...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • ellena-manuel
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

R eal-world

R eal-world

  • liane-varnes
  • 20 Slides

EVI. dence. on . S. troke prevention . I. n pati...

An Update on Reversal Agents for NOACs: Where Are

An Update on Reversal Agents for NOACs: Where Are

  • briana-ranney
  • 17 Slides

We Now?. Moderator. Christian T. Ruff, MD, MPH. A...

New Oral Anticoagulant

New Oral Anticoagulant

  • mitsue-stanley
  • 80 Slides

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

Update in the Perioperative and Emergency Management of Nov

Update in the Perioperative and Emergency Management of Nov

  • danika-pritchard
  • 47 Slides

Annelise Gallien, MD FRCPC. Moncton City Hospital...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • giovanna-bartolotta
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

The Novel Oral Anticoagulants

The Novel Oral Anticoagulants

  • tatyana-admore
  • 47 Slides

Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...

Safety and Efficacy of Uninterrupted Anticoagulation with

Safety and Efficacy of Uninterrupted Anticoagulation with

  • olivia-moreira
  • 28 Slides

Dabigatran . Etexilate versus Warfarin in Patient...

Stroke, Bleeding, and

Stroke, Bleeding, and

  • lois-ondreau
  • 7 Slides

Mortality Risks . in . Elderly Medicare Beneficia...

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

  • yoshiko-marsland
  • 25 Slides

(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....

ANTICOAGULATION Blake Wachter

ANTICOAGULATION Blake Wachter

  • olivia-moreira
  • 0 Slides

, MD, PhD . Monday Morning Conference. Oct 4, 201...

Trials and Tribulations in VTE:

Trials and Tribulations in VTE:

  • celsa-spraggs
  • 0 Slides

How Do Real-World Data Fit In? . Program Goals. V...

The direct oral anticoagulants (DOACs)

The direct oral anticoagulants (DOACs)

  • faustina-dinatale
  • 0 Slides

and major trauma. Dr. Tina . Biss. Consultant . ...

Pharmaceutical Management of Cardiac Medications:

Pharmaceutical Management of Cardiac Medications:

  • pamella-moone
  • 0 Slides

A Look at New Oral Anticoagulants. Linda Wing, . ...

Dabigatran in myocardial injury after noncardiac

Dabigatran in myocardial injury after noncardiac

  • lois-ondreau
  • 0 Slides

surgery. Dr. PJ Devereaux on behalf of . MANAGE I...

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

  • faustina-dinatale
  • 0 Slides

Fred V. Plapp MD PhD. Pathology and Laboratory Me...

Sandy Bartlett, PhD, PharmD

Sandy Bartlett, PhD, PharmD

  • mitsue-stanley
  • 0 Slides

, . BCPS, BCCCP. Associate Professor | Department...

Journal Club Jim Hoehns,

Journal Club Jim Hoehns,

  • cheryl-pisano
  • 0 Slides

Pharm.D. .. Edoxaban. Oral factor . Xa. inhibito...

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

  • phoebe-click
  • 0 Slides

NOACS IN AF. Where Do We Stand With NOACs in AF ...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • alexa-scheidler
  • 0 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

New Oral Anticoagulants: A Review

New Oral Anticoagulants: A Review

  • phoebe-click
  • 0 Slides

Babak Moini, MD. Veterans Affairs Hospital. Noon ...

Pharmacology of Anticoagulants

Pharmacology of Anticoagulants

  • conchita-marotz
  • 0 Slides

Nathan Culver, . PharmD. , BCPS. anticoagulant Me...

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

  • celsa-spraggs
  • 0 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider

NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider

  • debby-jeon
  • 0 Slides

Advantages of NOACs. No INR monitoring required. ...

CAD/PAD in Primary Care CV Risk in Stable Outpatients

CAD/PAD in Primary Care CV Risk in Stable Outpatients

  • stefany-barnette
  • 0 Slides

Stratified by Baseline CV Risk Category. Aspirin ...

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

  • giovanna-bartolotta
  • 15 Slides

Rivaroxaban Plus Aspirin in Patients With and Wit...

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

  • yoshiko-marsland
  • 18 Slides

Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...

Anticoagulation and Thrombosis Management

Anticoagulation and Thrombosis Management

  • pasty-toler
  • 14 Slides

Anticoagulation and Thrombosis Management A Revie...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • stefany-barnette
  • 22 Slides

A ssessment of D ual antiplatelet therapy versus...

Copyright © 2024 DocSlides. All Rights Reserved